Gemcitabine
From OncoWiki
Jump to navigationJump to search
Drug information
- Prescribing information (Lilly, PDF)
- Gemzar website (Lilly)
- Monograph (VIHA, PDF)
Indications
Biliary Tract Cancer
- Gemcitabine (Gemzar) 1000 mg/m2 iv d1, 8
- Q3w
References
Breast Cancer
- Gemcitabine (Gemzar) 725 mg/m2 iv qw x 3 wks evey 4wks
References
Ovarian Epithelial Cancer
Chemotherapy for recurrent or metastatic cancer
- Gemcitabine (Gemzar) 800-1000 mg/m2 iv over 1 h qw x 3 wks every 4 wks
References
Pancreatic Cancer
Adjuvant chemotherapy
- Gemcitabine (Gemzar) 1000 mg/m2 iv over 30 min qw x 3 weeks
- Q4w x 6 cycles
References
Chemotherapy for stage IV (metastatic) cancer
- Gemcitabine (Gemzar) 1000 mg/m2 iv over 30 min qw x 7 wks, followed by 1 w break, then weekly x 3 wks every 4 wks
References
Fixed-dose-rate Gemcitabine
- Gemcitabine (Gemzar) 1500 mg/m2 iv over 150 min qw x 3 wks every 4 wks
References
Poplin E et al. Phase III trial of gemcitabine (30-minute infusion) versus gemcitabine (fixed-dose-rate infusion [FDR) versus gemcitabine + oxaliplatin (GEMOX) in patients with advanced pancreatic cancer (E6201). 2006 ASCO annual meeting. Abstract LBA4004]
Lung Cancer Non Small Cell
Chemotherapy for stage IV (metastatic) cancer
- Gemcitabine (Gemzar) 1000 mg/m2 iv d 1, 8 and 15 q4w
References
Sarcoma
- Gemcitabine (Gemzar) 1200 mg/m2 iv over 120 min d1, 8 q3w